Endothelium-derived Microparticles Are Increased in Teenagers With Cobalamin Deficiency
- PMID: 34387625
- DOI: 10.1097/MPH.0000000000002286
Endothelium-derived Microparticles Are Increased in Teenagers With Cobalamin Deficiency
Abstract
Introduction: Vitamin B 12 (cobalamin) deficiency may be a significant cause of hyperhomocysteinemia, and high homocysteine (Hcy) levels are associated with an increased risk of cardiovascular disease. Endothelium-derived microparticles (EMPs) are a new marker in endothelial dysfunction and atherosclerosis, which play a role in cardiovascular diseases' pathogenesis. This study aimed to evaluate the EMPs, the markers of endothelial dysfunction and atherosclerosis, and lipid profile in teenagers with cobalamin deficiency.
Materials and methods: This prospective study included 143 teenagers, 75 vitamin B 12 deficient patients and 68 healthy controls between 11 and 18 years of age. Routine laboratory tests, hemogram, vitamin B 12 , folic acid, ferritin, Hcy, lipid profile and EMPs were examined and compared. EMP subgroups were analyzed by flow cytometry method according to the expression of membrane-specific antigens. The microparticles released from the endothelium studied were VE-cadherin (CD144), S-endo1 (CD146), and Endoglin (CD105).
Results: The present study demonstrates that circulating CD105+ EMP, CD144+ EMP, CD146+ EMPs, and Hcy were increased, and high-density lipoprotein (HDL) cholesterol was reduced in teenagers with cobalamin deficiency. Vitamin B 12 showed a negative correlation with EMPs and Hcy, positive correlation with folate and HDL. All EMPs showed a significant positive correlation with triglyceride, vitamin B 12 , and HDL.
Conclusion: Vitamin B 12 deficiency may predispose to endothelial damage and atherosclerosis by increasing EMPs and harms lipid metabolism in the long term.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Sezer RG, Bozaykut A, Akoglu HA, et al. The efficacy of oral vitamin B12 replacement for nutritional vitamin B12 deficiency. J Pediatr Hematol Oncol. 2018;40:e69–e72.
-
- Voutilainen S, Morrow JD, Roberts LJ II, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol. 1999;19:1263–1266.
-
- Baghersalimi A, Hemmati Kolachahi H, Darbandi B, et al. Assessment of serum folic acid and homocysteine in thalassemia major patients before and after folic acid supplement cessation. J Pediatr Hematol Oncol. 2018;40:504–507.
-
- Gursel O, Kurekci AE, Tascilar E, et al. Premature atherosclerosis in children with β-thalassemia major. J Pediatr Hematol Oncol. 2012;34:630–634.
-
- Sabry W, Elemary M, Burnouf T, et al. Vitamin B12 deficiency and metabolism-mediated thrombotic microangiopathy (MM-TMA). Transfus Apher Sci. 2020;59:102717.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
